Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 269

Results For "company"

5149 News Found

BioNTech appointing James Ryan as Chief Legal Officer
People | August 16, 2023

BioNTech appointing James Ryan as Chief Legal Officer

Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry


Boehringer Ingelheim receives FDA approval for Senvelgo to treat diabetes in cat
Drug Approval | August 16, 2023

Boehringer Ingelheim receives FDA approval for Senvelgo to treat diabetes in cat

Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus


Eugia Pharma receives USFDA Approval for Icatibant Injection
Drug Approval | August 16, 2023

Eugia Pharma receives USFDA Approval for Icatibant Injection

This is the 166th ANDA out of Eugia Pharma Speciality Group facilities


Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr
News | August 13, 2023

Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr

Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023


Krsnaa Diagnostics posts Q1 FY24 consolidated PAT at Rs. 14.64 Cr
News | August 13, 2023

Krsnaa Diagnostics posts Q1 FY24 consolidated PAT at Rs. 14.64 Cr

Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023


Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr
News | August 13, 2023

Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr

Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023


WuXi XDC and Boostimmune sign MoU for integrated services
News | August 13, 2023

WuXi XDC and Boostimmune sign MoU for integrated services

Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform


Gujarat Themis Biosyn posts Q1 FY24 PAT at Rs. 17.72 Cr
News | August 12, 2023

Gujarat Themis Biosyn posts Q1 FY24 PAT at Rs. 17.72 Cr

Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023


IPCA Laboratories posts Q1 FY24 consolidated PAT at Rs. 162.82 Cr
News | August 12, 2023

IPCA Laboratories posts Q1 FY24 consolidated PAT at Rs. 162.82 Cr

IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023


SMS Lifesciences India posts Q1 FY24 consolidated loss at Rs. 1.79 Cr
News | August 10, 2023

SMS Lifesciences India posts Q1 FY24 consolidated loss at Rs. 1.79 Cr

The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023